Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Pompilio A, Piccolomini R, Picciani C, D’Antonio D, Savini V, Di Bonaventura G: Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. FEMS Microbiol. Lett.287,41–47 (2008).
  Medline CASGoogle Scholar
• 2  Ryan RP, Monchy S, Cardinale M et al.: The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol.7,514–525 (2009).
  Medline CASGoogle Scholar
• 3  Passerini de Rossi B, Calenda M, Vay C, Franco M: Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev. Argent Microbiol.39,204–212 (2007).
  Medline CASGoogle Scholar
• 4  Calza L, Manfredi R, Chiodo F: Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection31,155–161 (2003).
  Medline CASGoogle Scholar
• 5  Looney WJ, Narita M, Muhlemann K: Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis.9,312–323 (2009).▪ Describes methods for the prevention and management of Stenotrophomonas maltophilia infections.
  Medline CASGoogle Scholar
• 6  Safdar A, Rolston KV: Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin. Infect. Dis.45,1602–1609 (2007).
  MedlineGoogle Scholar
• 7  Sakhnini E, Weissmann A, Oren I: Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am. J. Med. Sci.323,269–272 (2002).
  Medline CASGoogle Scholar
• 8  Lai CH, Chi CY, Chen HP et al.: Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J. Microbiol. Immunol. Infect.37,350–358 (2004).
  MedlineGoogle Scholar
• 9  Spicuzza L, Sciuto C, Vitaliti G, Di Dio G, Leonardi S, La Rosa M: Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis.28,191–195 (2009).
  Medline CASGoogle Scholar
• 10  Denton M, Kerr KG: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev.11,57–80 (1998).▪ Review on the taxonomic status, laboratory identifications, risk factors for acquisition and therapy of S. maltophilia.
  Medline CASGoogle Scholar
• 11  Figueiredo PM, Furumura MT, Santos AM et al.: Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett. Appl. Microbiol.43,443–449 (2006).
  Medline CASGoogle Scholar
• 12  Hagemann M, Hasse D, Berg G: Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas maltophilia. Arch. Microbiol.185,449–458 (2006).
  Medline CASGoogle Scholar
• 13  McKay GA, Woods DE, MacDonald KL, Poole K: Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect. Immun.71,3068–3075 (2003).
  Medline CASGoogle Scholar
• 14  Wu PS, Lu CY, Chang LY et al.: Stenotrophomonas maltophilia bacteremia in pediatric patients: a 10-year analysis. J. Microbiol. Immunol. Infect.39,144–149 (2006).
  MedlineGoogle Scholar
• 15  Tsai WP, Chen CL, Ko WC, Pan SC: Stenotrophomonas maltophilia bacteremia in burn patients. Burns32,155–158 (2006).
  MedlineGoogle Scholar
• 16  Boktour M, Hanna H, Ansari S et al.: Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer106,1967–1973 (2006).
  MedlineGoogle Scholar
• 17  Caylan R, Aydin K, Koksal I: Meningitis caused by Stenotrophomonas maltophilia: case report and review of the literature. Ann. Saudi Med.22,216–218 (2002).
  MedlineGoogle Scholar
• 18  Gasparetto EL, Bertholdo DB, Davaus T, Marchiori E, Escuissato DL: Stenotrophomonas maltophilia pneumonia after bone marrow transplantation: case report with emphasis on the high-resolution CT findings. Br. J. Radiol.80,e19–e20 (2007).
  Medline CASGoogle Scholar
• 19  Marshall WF, Keating MR, Anhalt JP, Steckelberg JM: Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin. Proc.64,1097–1104 (1989).
  Medline CASGoogle Scholar
• 20  Teo WY, Chan MY, Lam CM, Chong CY: Skin manifestation of Stenotrophomonas maltophilia infection – a case report and review article. Ann. Acad. Med. Singapore35,897–900 (2006).
  MedlineGoogle Scholar
• 21  Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G: Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis.28,719–730 (2009).▪▪ Reviews the importance of S. maltophilia beyond nosocomial infections.
  Medline CASGoogle Scholar
• 22  Alonso A, Martinez JL: Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.41,1140–1142 (1997).
  Medline CASGoogle Scholar
• 23  Gattuso G, Tomasoni D, Ceruti R, Scalzini A: Multiresistant Stenotrophomonas maltophilia tunneled CVC-related sepsis, treated with systemic and lock therapy. J. Chemother.16,494–496 (2004).
  Medline CASGoogle Scholar
• 24  Looney WJ: Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br. J. Biomed. Sci.62,145–154; quiz 1 p following 154 (2005).
  Medline CASGoogle Scholar
• 25  Tan CK, Liaw SJ, Yu CJ, Teng LJ, Hsueh PR: Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn. Microbiol. Infect. Dis.60,205–210 (2008).
  Medline CASGoogle Scholar
• 26  Zhang L, Li XZ, Poole K: Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob. Agents Chemother.44,287–293 (2000).
  Medline CASGoogle Scholar
• 27  Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR: Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J. Antimicrob. Chemother.62,889–894 (2008).▪▪ Assessment of treatment of this difficult-to-treat pathogen.
  Medline CASGoogle Scholar
• 28  Nicodemo AC, Paez JI: Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis.26,229–237 (2007).
  Medline CASGoogle Scholar
• 29  Muder RR: Optimizing therapy for Stenotrophomonas maltophilia. Semin. Respir. Crit. Care Med.28,672–677 (2007).
  MedlineGoogle Scholar
• 30  Turkoglu MA, Iskit AT: Ventilator-associated pneumonia caused by high risk microorganisms: a matched case–control study. Tuberk. Toraks56,139–149 (2008).
  MedlineGoogle Scholar
• 31  Metan G, Hayran M, Hascelik G, Uzun O: Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand. J. Infect. Dis.38,527–531 (2006).
  MedlineGoogle Scholar
• 32  Nseir S, Di Pompeo C, Brisson H et al.: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit. Care10,R143 (2006).
  MedlineGoogle Scholar
• 33  Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR: Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin. Infect. Dis.34,1653–1656 (2002).▪▪ First matched case–control trial concentrating on and attributing mortality to S. maltophilia infection.
  MedlineGoogle Scholar
• 34  Elting LS, Khardori N, Bodey GP, Fainstein V: Nosocomial infection caused by Xanthomonas maltophilia: a case–control study of predisposing factors. Infect. Control Hosp. Epidemiol.11,134–138 (1990).▪ One of the first evaluations of predisposing factors for infection with S. maltophilia.
  Medline CASGoogle Scholar
• 35  Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK: Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA246,1571–1574 (1981).
  Medline CASGoogle Scholar
• 36  Guriz H, Ciftci E, Ayberkin E et al.: Stenotrophomonas maltophilia bacteraemia in Turkish children. Ann. Trop. Paediatr.28,129–136 (2008).
  MedlineGoogle Scholar
• 37  Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K, Raad I: Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer109,2615–2622 (2007).
  MedlineGoogle Scholar
• 38  Kagen J, Zaoutis TE, McGowan KL, Luan X, Shah SS: Bloodstream infection caused by Stenotrophomonas maltophilia in children. Pediatr. Infect. Dis. J.26,508–512 (2007).
  MedlineGoogle Scholar
• 39  Apisarnthanarak A, Mayfield JL, Garison T et al.: Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case–control study. Infect. Control Hosp. Epidemiol.24,269–274 (2003).
  MedlineGoogle Scholar
• 40  Labarca JA, Leber AL, Kern VL et al.: Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin. Infect. Dis.30,195–197 (2000).
  Medline CASGoogle Scholar
• 41  Micozzi A, Venditti M, Monaco M et al.: Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin. Infect. Dis.31,705–711 (2000).
  Medline CASGoogle Scholar
• 42  Victor MA, Arpi M, Bruun B, Jonsson V, Hansen MM: Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand. J. Infect. Dis.26,163–170 (1994).▪▪ First case–control study analyzing epidemiological, microbiological and clinical characteristics of S. maltophilia.
  Medline CASGoogle Scholar
• 43  Maningo E, Watanakunakorn C: Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J. Infect.31,89–92 (1995).
  Medline CASGoogle Scholar
• 44  Hanes SD, Demirkan K, Tolley E et al.: Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin. Infect. Dis.35,228–235 (2002).
  MedlineGoogle Scholar
• 45  Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A: Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur. J. Clin. Microbiol. Infect. Dis.26,13–20 (2007).
  Medline CASGoogle Scholar
• 46  Villarino ME, Stevens LE, Schable B et al.: Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect. Control Hosp. Epidemiol.13,201–206 (1992).
  Medline CASGoogle Scholar
• 47  Kwa AL, Low JG, Lee E, Kurup A, Chee HL, Tam VH: The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia. Diagn. Microbiol. Infect. Dis.58,99–104 (2007).
  Medline CASGoogle Scholar
• 48  McGowan JE Jr: Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med.119,S29–S36; discussion S62–S70 (2006).
  Medline CASGoogle Scholar
• 49  Penzak SR, Abate BJ: Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen. Pharmacotherapy17,293–301 (1997).▪ Focuses on the treatment of S. maltophilia infections.
  Medline CASGoogle Scholar
• 50  Rousseau A, Morcos M, Amrouche L et al.: Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk. Lymphoma45,1293–1296 (2004).
  MedlineGoogle Scholar
• 51  Pathmanathan A, Waterer GW: Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur. Respir. J.25,911–914 (2005).
  Medline CASGoogle Scholar
• 52  Dupont H, Mentec H, Sollet JP, Bleichner G: Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med.27,355–362 (2001).
  Medline CASGoogle Scholar
• 53  Mueller EW, Hanes SD, Croce MA, Wood GC, Boucher BA, Fabian TC: Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J. Trauma58,94–101 (2005).
  MedlineGoogle Scholar
• 54  Paez J, Costa S: Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia. J. Hosp. Infect.70,101–108 (2008).
  MedlineGoogle Scholar
• 55  Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW: Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J. Infect.45,47–53 (2002).
  Medline CASGoogle Scholar
• 56  del Toro MD, Rodriguez-Bano J, Martinez-Martinez L et al.: Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia. Enferm. Infecc. Microbiol. Clin.24,4–9 (2006).
  MedlineGoogle Scholar
• 57  Gopalakrishnan R, Hawley HB, Czachor JS, Markert RJ, Bernstein JM: Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients. Heart Lung28,134–141 (1999).
  Medline CASGoogle Scholar